| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Mirum Pharmaceuticals, Inc. (MIRM) has 13 insiders with recent SEC Form 4 filings, including 2 buys and 8 sells. MIRM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 108.5K | $10.74M | - | |
| CFO | 47.2K | $4.67M | - | |
| COO | 40.3K | $3.99M | - | |
| Other | 18.9K | $1.87M | - | |
| Dir | 3.8K | $373.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 27, 2024 | Bjerkholt Eric71 | Chief Financial Officer | Buy | 2,000 | $24.80 | $49,600.00 | +16.7% | +31.9% | +83.4% | |
| Mar 25, 2024 | Radovich Peter | President And COO | Sell | 4,303 | $25.80 | $111,017.40 | -12.9% | +33.3% | +80.0% | |
| Mar 18, 2024 | Bjerkholt Eric71 | Chief Financial Officer | Buy | 2,000 | $25.80 | $51,600.00 | +20.0% | +27.0% | +70.6% | |
| Feb 2, 2024 | Radovich Peter | President And COO | Sell | 1,790 | $26.19 | $46,883.14 | -4.9% | -3.5% | +84.3% | |
| Feb 2, 2024 | Vig Pamela | Chief Scientific Officer | Sell | 1,214 | $26.19 | $31,796.85 | -4.1% | -3.5% | +84.3% | |
| Feb 2, 2024 | Longpre Lara | Chief Development Officer | Sell | 847 | $26.19 | $22,184.45 | -0.8% | -3.5% | +84.3% | |
| Feb 2, 2024 | Peetz Christopher45 | Chief Executive Officer | Sell | 6,013 | $26.19 | $157,491.29 | -5.5% | -3.5% | +84.3% | |
| Feb 2, 2024 | Howe Jolanda | SVP, Global Controller | Sale+OE | 735 | $26.19 | $19,250.97 | -29.5% | -3.5% | +84.3% | |
| Jan 8, 2024 | Radovich Peter | Chief Operating Officer | Sell | 1,408 | $28.03 | $39,472.58 | -3.7% | -9.1% | +47.5% | |
| Jan 8, 2024 | Longpre Lara | Chief Development Officer | Sell | 1,019 | $28.04 | $28,567.67 | -1.0% | -9.1% | +47.5% |